Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.20p
   
  • Change Today:
      0.30p
  • 52 Week High: 14.13
  • 52 Week Low: 1.85
  • Currency: UK Pounds
  • Shares Issued: 132.35m
  • Volume: 1,538,614
  • Market Cap: £2.91m
  • RiskGrade: 435

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
05-Nov-15 Northland Capital Partners Corporate 26.00p - - Reiteration
14-Oct-14 Daniel Stewart Buy - 1.05p 1.05p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Valirx Market Data

Currency UK Pounds
Share Price 2.20p
Change Today 0.30p
% Change 15.79 %
52 Week High 14.13
52 Week Low 1.85
Volume 1,538,614
Shares Issued 132.35m
Market Cap £2.91m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
6.35% below the market average6.35% below the market average6.35% below the market average6.35% below the market average6.35% below the market average
13.73% above the sector average13.73% above the sector average13.73% above the sector average13.73% above the sector average13.73% above the sector average
Price Trend
96.64% below the market average96.64% below the market average96.64% below the market average96.64% below the market average96.64% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth Not Available

Valirx Dividends

No dividends found

Trades for 17-May-2024

Time Volume / Share Price
16:36 750,000 @ 1.85p
16:40 9,886 @ 2.20p
16:40 386 @ 2.20p
16:40 9,500 @ 2.20p
16:29 25,283 @ 1.94p

Valirx Key Personnel

CFO Gerald Desler
CEO Suzanne Dilly

Top of Page